Were normalized with medium-stimulated samples.In vitro Antigen Presentation AssaysBMDC (3000 cells) were incubated overnight in 96-well culture plates either with media or OVA. T cells obtained from the lymph nodes and the spleen of OT-I and OT-II Rag-22/2 mice were purified with the T cell enrichment kit from Dynal following manufacturer’s instructions. For CD4 and CD8 T cell proliferation assays, purified T cells were labeled with 10 mM carboxyfluorescein diacetate succinimidyl ester (CFSE from Invitrogen) for 10 min at 37uC. OT-II and OT-I cells (20000 cells) were added to BMDC that had been stimulated 1531364 for 8 h with different LPS and then washed. The proliferation of OT-I and OT-II T cells was assessed 23115181 after 3 days of co-culture by flow cytometry. The cells were washed and stained with anti-CD4 and anti-CD8 antibodies for identification. For CD4 and CD8 T cell activation assays, purified T cells were co-cultured with BMDC previously stimulated for 8 h with different LPS. After 3 days, the expression of surface markers such as CD25, CD44 and CD62LStatistical AnalysisAll experiments were carried out at least 3 independent times and all the results correspond to the means 6 standard errors.Tetraacyl LPS Potentiate Intracellular SignallingStatistical analysis was done using two-tailed unpaired Student’s t test. Significance was defined when P values were ,0.05.Results Structural Modifications of LPS Affect Cytokine Secretion by DCWe used an array of LPS (Table 1) differing in lipid A CP21 chemical information acylation to study their activation properties in mouse bone marrow-derived dendritic cells (BMDC) and bone marrow-derived macrophages (BMDM). In addition to the classical wild type hexa-acyl LPS purified from E. coli MLK strain, we used LPS from E. coli MLK mutants (msbB-, htrB- and msbB2/htrB- double mutant) that produce mostly penta-acyl and tetra-acyl lipid A (Table 1) or LPS purified from Y. pestis KIM grown at 37uC (mainly composed of tri- and tetra-acyl lipid A with small amounts of penta-acyl and hexa-acyl molecules, Table 1). All LPS variants induced a BMDC maturation characterized by an up-regulation of the surface expression of major histocompatibility complex MHC-II and costimulatory molecules (CD40, CD86) (Figure 1A). However, significant lower levels of secreted TNF-a and IL-12 were detected in DC stimulated by tetra-acyl LPS purified from E. coli MLK (msbB2/htrB-) double mutants or LPS purified from Y. pestis compared to DC stimulated with wild type E. coli hexa-acyl LPS (Figure 1B). Moreover, the LPS variants did not induce any IFNa secretion (not shown). While comparing the activities of LPS variants, we have also performed a dose-response study (not shown). Cell treatment by 1 ng/ml of LPS 76932-56-4 chemical information triggered DC activation, which reached a plateau at the highest concentration (100 ng/ml). The same differences in terms of cytokine secretion were observed when cells were treated both with 100 ng/ml and 10 ng/ml of different LPS (not shown). Similarly, in BMDM activated by tetra-acyl LPS, TNF-a secretion was strongly decreased compared to BMDM incubated with hexa-acyl LPS (Figure S1) as previously observed in macrophage cell lines [8,9,10]. We then tested the ability of tetra-acyl LPS (referred as purified either from E. coli MLK msbB2/htrB- double mutant or Y. pestis grown at 37uC) to induce human blood myeloid DC (mDC) activation (Figure 1C and D). Hexa-acyl and tetra-acyl LPS induced a similar up-regulation of classical cell surface activation marker.Were normalized with medium-stimulated samples.In vitro Antigen Presentation AssaysBMDC (3000 cells) were incubated overnight in 96-well culture plates either with media or OVA. T cells obtained from the lymph nodes and the spleen of OT-I and OT-II Rag-22/2 mice were purified with the T cell enrichment kit from Dynal following manufacturer’s instructions. For CD4 and CD8 T cell proliferation assays, purified T cells were labeled with 10 mM carboxyfluorescein diacetate succinimidyl ester (CFSE from Invitrogen) for 10 min at 37uC. OT-II and OT-I cells (20000 cells) were added to BMDC that had been stimulated 1531364 for 8 h with different LPS and then washed. The proliferation of OT-I and OT-II T cells was assessed 23115181 after 3 days of co-culture by flow cytometry. The cells were washed and stained with anti-CD4 and anti-CD8 antibodies for identification. For CD4 and CD8 T cell activation assays, purified T cells were co-cultured with BMDC previously stimulated for 8 h with different LPS. After 3 days, the expression of surface markers such as CD25, CD44 and CD62LStatistical AnalysisAll experiments were carried out at least 3 independent times and all the results correspond to the means 6 standard errors.Tetraacyl LPS Potentiate Intracellular SignallingStatistical analysis was done using two-tailed unpaired Student’s t test. Significance was defined when P values were ,0.05.Results Structural Modifications of LPS Affect Cytokine Secretion by DCWe used an array of LPS (Table 1) differing in lipid A acylation to study their activation properties in mouse bone marrow-derived dendritic cells (BMDC) and bone marrow-derived macrophages (BMDM). In addition to the classical wild type hexa-acyl LPS purified from E. coli MLK strain, we used LPS from E. coli MLK mutants (msbB-, htrB- and msbB2/htrB- double mutant) that produce mostly penta-acyl and tetra-acyl lipid A (Table 1) or LPS purified from Y. pestis KIM grown at 37uC (mainly composed of tri- and tetra-acyl lipid A with small amounts of penta-acyl and hexa-acyl molecules, Table 1). All LPS variants induced a BMDC maturation characterized by an up-regulation of the surface expression of major histocompatibility complex MHC-II and costimulatory molecules (CD40, CD86) (Figure 1A). However, significant lower levels of secreted TNF-a and IL-12 were detected in DC stimulated by tetra-acyl LPS purified from E. coli MLK (msbB2/htrB-) double mutants or LPS purified from Y. pestis compared to DC stimulated with wild type E. coli hexa-acyl LPS (Figure 1B). Moreover, the LPS variants did not induce any IFNa secretion (not shown). While comparing the activities of LPS variants, we have also performed a dose-response study (not shown). Cell treatment by 1 ng/ml of LPS triggered DC activation, which reached a plateau at the highest concentration (100 ng/ml). The same differences in terms of cytokine secretion were observed when cells were treated both with 100 ng/ml and 10 ng/ml of different LPS (not shown). Similarly, in BMDM activated by tetra-acyl LPS, TNF-a secretion was strongly decreased compared to BMDM incubated with hexa-acyl LPS (Figure S1) as previously observed in macrophage cell lines [8,9,10]. We then tested the ability of tetra-acyl LPS (referred as purified either from E. coli MLK msbB2/htrB- double mutant or Y. pestis grown at 37uC) to induce human blood myeloid DC (mDC) activation (Figure 1C and D). Hexa-acyl and tetra-acyl LPS induced a similar up-regulation of classical cell surface activation marker.
